Over the last three years, Ho Chi Minh City-based Medigo has grown to 500,000 active users by providing 24/7 one-demand prescription delivery services. Now it’s planning to grow its telehealth ecosystem with $2 million in new funding by East Ventures, with participation from Pavilion Capital and Touchstone Partners.
The new capital will allow Medigo to expand its remote doctor consultations, medicine delivery services and home testing services, including blood tests, urine tests and pregnancy tests.
Medigo’s app connects users to nearby licenses pharmacies and delivers medicine within 20 minutes. It currently has 1,000 pharmacy partners in Hanoi, Da Nang and Ho Chi Minh City, Vietnam’s three biggest cities, and will began expanding to Tier 2 cities, like Binh Duong, Vung Tau and Hai Phong, this year.
The startup’s CEO and co-fouder Ha Le began working on the app after he had trouble finding fever reducers for his daughter in the middle of the night. “When I was in university as a software engineer, I never thought that working in the healthcare space would be the center of my daily life, but now, it is my life’s mission,” he told TechCrunch.
Medigo has plenty of competitors, including Doctor Anywhere, Jio Health, Edoctor, Long Chau, Pharmacity and Rightnow. Le said Medigo differentiates by working with pharmacies that are open around the clock so it is able to operate 24/7 consistently. It also plans to connect different providers, so users can have more choices on the same platform.
In a statement about the investment, East Ventures managing partner Koh Wai Kit said, “Digital technologies can improve the accessibility and affordability of good quality healthcare. We are excited by Medigo’s mission to revolutionize pharmacies and healthcare services in Vietnam.”
Biotech proved a surprisingly bright spot in 2022’s startup correction
